• The Criticality Of API CDMO Selection: Insights From A Client
    The Criticality Of API CDMO Selection: Insights From A Client

    4SC AG, a clinical-stage biopharmaceutical company partnered with Patheon, by Thermo Fisher Scientific, whose experienced team helped them overcome active pharmaceutical ingredient (API) manufacturing hurdles, leading to a path toward commercial success.



  • Standing Out In The Crowded Biopharma CDMO Market
    Standing Out In The Crowded Biopharma CDMO Market

    When CDMOs understand what motivates drug innovators to outsource, who is involved in the service provider selection decision, and which CDMO attributes have the greatest influence on CDMO selection they are able to communicate what is unique about their offering to the right audience at the right time. 

  • Singota Solutions—Focused on Faster

    This video introduces Singota Solutions, a CDMO focused on getting products to patients faster by being agile, accountable and transparent. A team of industry experts help virtual to large pharma clients reach preclinical and clinical milestones faster with shorter lead times and agile onsite operations. Services in formulation development, finishing and supply chain support Singota’s flagship aseptic filling operations. A gloveless robotic isolator provides highly repeatable and precise filling for high value drug products.

  • How Adaptable Manufacturing Models Are Paving A Path Into An Unpredictable Future

    Joe Principe, Vice President of Strategic Partnerships, Patheon, discusses the new set of “must-haves” that are emerging from the increased need for flexibility in outsourced manufacturing partnerships.

  • 5 Key Considerations For Successfully Creating cGMP Single-Use Biomanufacturing Capacity

    Single-use technologies are being seen as the solution to flexibly and cost-effectively address many of the challenges around creating biologics manufacturing capacity.

  • Contained Manufacturing Operations Update From Penn Pharma

    Pharmaceutical manufacturer and developer, Penn Pharma, has confirmed that its new contained manufacturing facility for producing highly potent products is on track for opening Q1 2013 at an exclusive event held at the British Embassy, Madrid during ICSE.

More Contract Pharma Manufacturing Multimedia


  • Mammalian Cell Culture: Process R&D Services

    Lonza’s global R&D center for mammalian cell processes is based in Slough, UK alongside a custom manufacturing facility. Lonza undertakes highly specialized development and manufacturing services for the pharmaceutical and biotechnology industries. Read more about Lonza’s complete range of R&D Services and an array of technologies and skills to best match their customers’ requirements for all stages of product development.

  • Surfactant Analysis Services

    Successful drug product development should integrate formulation, manufacturing process, primary packaging, device and delivery to the patient. Lonza’s Drug Product Services (DPS) offering delivers a holistic approach to DP development that anticipates and prevents problems early, and ensures the result is a product that is fit for purpose.

  • Microbiological Testing
    Microbiological Testing

    With nearly 30 years’ experience in supporting all compendial microbiological testing, Nitto Avecia Pharma Services has the in-depth experience, established quality systems, and expertise to best support your product life cycle at any stage.

More Pharmaceutical Manufacturing Solutions


DIA 2019 Global Annual Meeting June 23 - 27, 2019
San Diego, CA
Reacting to “Human Error” – Moving Beyond “Retraining” As A Response June 26 - 26, 2019
1pm-2:30pm EDT, Online Training
Price:  $299 - Includes Bonus Handouts!
22nd International Conference and Exhibition on P July 4 - 6, 2019
Valencia, Spain
Executing Proper Event Investigations: Critical Steps In Ensuring Compliant Corrective Actions July 10 - 10, 2019
1pm-2:30pm EDT, Online Training
Duration:  90-Minutes
Price:  $199 - Includes Bonus Handouts!